Publications by authors named "P Taniere"

Claim this Profile
F
Final results of ANICCA-Class II, a single arm, open-label phase II trial assessing nivolumab in tissue-specific class II expressing metastatic microsatellite stable colorectal cancer, with a parallel assessment of the immunoscore-immune checkpoint as a predictive biomarker for single-agent anti-PD-1.
Gary Middleton, Charlotte Gaskell, Joshua Savage, John Bridgewater, Paul Ross, Phillipe Taniere

J Immunother Cancer· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
From barriers to solutions: an expert-based algorithm for cholangiocarcinoma and other biliary tract cancers testing in the Era of precision oncology.
Albrecht Stenzinger, Nicola Normanno, Angela Lamarca, Lorenza Rimassa, Fréderic Bibeau, Philippe Taniere

Expert Rev Mol Diagn· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A Retrospective Evaluation of PD-L1 Expression and Heterogeneity in Early-Stage Non-Small Cell Lung Cancer (REPLICA).
Eleni C Josephides, Daniel Smith, Andrea Bille, Akshay Patel, Hannah L Rush, Phillipe Taniere

Clin Lung Cancer· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Results of a modified Delphi consensus on the optimal testing pathway for oesophago-gastric cancer care in the UK.
Manuel Rodriguez-Justo, Wasat Mansoor, Thomas Bird, Martin Eatock, Naureen Starling, Philippe Taniere

BMJ Open· February 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Best-Practice Biomarker Testing of Oesophago-Gastric Cancer in the UK: Expert Consensus Recommendations Developed Using a Modified Delphi.
N P West, W Mansoor, P Taniere, E Smyth, M Rodriguez-Justo

Clin Oncol (R Coll Radiol)· November 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis